By Beatrice Puente
(September 10, 2021) – The embattled Pharmally Pharmaceutical Corporation should fully disclose its tax returns in 2020 to explain the possible P402 million tax deficiency due to potential underdeclaration of records, an independent analysis of the company’s audited financial statement showed.
Two certified public accountants, Jahleel-AN Burao and John Michael Lava, worked with the Citizens’ Budget Tracker and the Right to Know, Right Now! Coalition to assess the audited financial report of the controversial firm, flagging five high-risk observations.
They said Pharmally Pharmaceutical Corporation only paid the value-added tax (VAT) for P3.89 billion purchases for inventory and capital goods, recomputing the amount based on disclosures. But the audit showed the company’s purchases amounted to P7.2 billion, posing a discrepancy of P3.35 billion. Its 12% VAT is P402.2 million.
“The difference could be related to the imports of certain medical goods which are exempted from all import duties and taxes in response to the COVID-19 pandemic,” said the report. “However, whether purchases of Pharmally relate to exempt transactions cannot be ascertained in the note disclosures.”
? ????????? ???? – The Citizens’ Budget Tracker and the Right to Know, Right Now! Coalition have worked together on this…
Posted by Right to Know Right Now Coalition on Monday, September 6, 2021
Lawmakers have raised concerns that the company, which provided overpriced COVID-19 supplies for the Department of Health, might have only acted as a trading firm and not a manufacturing company, sourcing the face masks, face shields, and other supplies from China.
Some imported supplies can be tax-exempt only if they are not readily available in the country, according to government regulations. To clarify the matter, the report urged Pharmally Pharmaceutical Corporation to release its certification from the Department of Trade and Industry.
“If the purchases are a mix of foreign- and locally-sourced items, then this raises the concern why importations were made if the items are locally available,” added the report.
‘High risk’
Pharmally Pharmaceutical Corporation, linked to former economic adviser Michael Yang, obtained P8.68 billion worth of procurement contracts from the Department of Budget and Management despite having a measly starting capital of P625,000. It is not enough to warrant P7.9 billion worth of deals awarded from April to June alone since it falls below the acceptable Net Financial Contracting Capacity (NFCC), said the report.
At the minimum, the company should have at least P6.24 million in its working capital as of April 2020 to carry the approved P62.4 million budget for the first contract. It became more insufficient in the succeeding days when it bagged two more contracts amounting to P985 million.
“While meeting the NFCC is not a mandatory requirement, it is worth looking into this figure to approximate a company’s ability to fulfill its contractual obligations,” continued the report, noting the “very high risk” of default and insolvency given the low capital.
Senators hit the PS-DBM for favoring Pharmally Pharmaceutical Corporation when other local suppliers would have been able to supply the same requirements.
EMS Components Assembly, a local producer that won one contract, lamented its losses as the DBM allegedly delayed the delivery of the COVID-19 supplies. It provided the lowest price for face masks at P13.50 per piece, way below the P22.50 supplied by Pharmally Pharmaceutical Corporation.
President Rodrigo Duterte, who vowed not to tolerate even a “whiff of corruption,” has repeatedly lambasted senators for their investigation into the dubious transactions. He insisted there was no corruption in any of the deals but promised to step down, as he has repeatedly said so in the past, if the allegations are proven true.
Yang, who ignored subpoenas for the legislative hearings, showed up this afternoon.
(PM)
Our Privacy Commitment
TV5 Network Inc. values and respects your privacy. We are committed to safeguarding your personal data in compliance with Republic Act No. 10173 or the Data Privacy Act of 2012 and its implementing rules and regulations.
We have developed a Privacy Policy that adopts and observes appropriate standards for personal data protection. While our Privacy Policy sets out the general principles governing the collection, use, and disclosure of our users’ personal information, our Privacy Commitment seeks to inform you more about TV5’s privacy practices.
Why do we collect your personal information (as applicable)?
We may collect and maintain basic information about you as site user of TV5 sites for the following purposes:
Where do we get your personal information?
There are several ways we collect your personal information.
Information that you personally provided.
Most of the personal information we have are those that you have provided us when you:
Information we collect during your engagement with us
We also collect information as you use our products and services, like:
Information we collect from other sources
Other means of collection of information may be through:
When do we disclose personal information?
There may be instances when we are required to share the information you provided us. In such cases, we ensure that your personal information will be disclosed on a confidential manner, through secure channels and in compliance with the Data Privacy Act and other privacy laws.
We will never share, rent, or sell your personal information to third parties outside of TV5 except in special cases where you have given consent, and in cases described in our privacy policy.
In some instances, we may be required to disclose your personal information to our agents, subsidiaries, affiliates, business partners and other third-party agencies and service providers as part of our regular business operations and for the provision of our programs and services. This means we might share your information with our service providers, contractors, and professional advisers who help us provide our services.
How we protect your personal information
The integrity, confidentiality, and security of your information is important to us. We have implemented technical, organizational, and physical security measures that are designed to protect your information from unauthorized or fraudulent access, alteration, disclosure, misuse, and other unlawful activities.
We also put in effect the following safeguards:
TV5 will not collect, use, or disclose your personal information for any purpose other than the purpose that you may have given your consent for.
What are your choices?
We make sure that we have your consent to continue to collect, use, and disclose your personal information for the purposes that we have identified. We want you to know that you may object or withdraw your consent and/or edit your consent preferences at any time.
If you wish to have access to the personal information in our custody or if you think that the personal information you provided is incomplete, or otherwise inaccurate, you may get in touch with our Data Protection Officer through the contact details provided below. In some instances, we may request for supporting documents or proof before we effect requested changes.
Data Protection Officer
TV5 Network Inc.
Reliance corner Sheridan Streets
Mandaluyong City
tv5dataprivacy@tv5.com.ph
What happens when there are changes in our Policy?
From time to time, we may update our privacy policy and practices to comply with changes in applicable laws and regulatory requirements, adapt to new technologies and protocols, and align with the best practices of the industry.
You will be provided notices if the changes are significant and, if we are required by law, we will obtain your updated consent.